In the competitive world of life science investment, timing your funding approach is critical. Too early, and you lack the evidence to stand out; too late, and you risk running out of cash. Focus on building a strong quality culture and gather solid proof of your market potential before pitching to VCs and angels to make your story compelling and credible.
In the hunt for life science investment funding, timing is everything. Wait too long, and you run out of cash. Move too early, and there’s not enough color and evidence to help you stand out from the pack. VCs and angels won’t flock to untested ideas and concepts in the current age of tight money - so gather evidence of a successful pathway to market before you approach them. Work hard to push a culture of quality before norms settle and crystallize. Hire people with quality expertise, push quality-centric policies and procedures, and have a high-quality operation to shout about when pitch time arrives. And use journals and industry publications to pinpoint the size of your total addressable market (TAM) - quantify your product’s realistic impact on the market and have it ready to discuss. Telling a good story is now more important than ever.
